US Stock MarketDetailed Quotes

RAPT RAPT Therapeutics

Watchlist
  • 1.230
  • +0.110+9.82%
Close Nov 27 16:00 ET
  • 1.190
  • -0.040-3.25%
Post 18:39 ET
43.00MMarket Cap-442P/E (TTM)

RAPT Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

RAPT Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--

Unlock Free Earnings Estimates

RAPT Therapeutics Earnings Reports

  • RAPT Therapeutics | 10-Q: Q3 2024 Earnings Report

    Nov 12 12:04 ET

  • RAPT Therapeutics | 8-K: RAPT Therapeutics Reports Third Quarter 2024 Financial Results

    Nov 12 09:36 ET

  • RAPT Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 8 08:14 ET

  • RAPT Therapeutics | 8-K: RAPT Therapeutics Reports Second Quarter 2024 Financial Results

    Aug 8 08:09 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 13, 2024

    Hold

    • Buy

      14.29%

    • Hold

      71.43%

    • Sell

      14.29%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data